Pompe disease is a rare inherited condition associated with changes in the GAA gene. This gene provides instructions for producing an enzyme that helps break down glycogen within cells. When GAA gene changes reduce or eliminate enzyme activity, glycogen can accumulate and affect muscles and other tissues.
Pompe disease is a genetic disorder that develops when changes, also called variants or mutations, occur in the GAA gene. The GAA gene contains instructions for producing acid alpha glucosidase, an enzyme involved in breaking down glycogen inside cellular structures called lysosomes. When this enzyme is absent or does not function effectively, glycogen can gradually accumulate within cells. This accumulation may affect the normal function of muscles and other tissues, leading to different forms and levels of disease severity.
The GAA gene is inherited from parents and plays an important role in producing the acid alpha glucosidase enzyme. Individuals with Pompe disease generally inherit disease-causing changes in both copies of the GAA gene. The condition is usually inherited in an autosomal recessive pattern, meaning that a person typically receives one altered gene copy from each parent.
Different GAA gene changes can influence how much enzyme activity remains in the body. Some changes may result in very little or no functional enzyme, while others may allow a certain level of enzyme activity. These differences can contribute to variation in the age at which symptoms appear and how the condition develops.
The effects of these genetic changes are not always identical among individuals. The relationship between a specific variant and disease progression can be influenced by the amount of remaining enzyme activity and other biological factors.
When acid alpha glucosidase activity is reduced, glycogen is not broken down normally within lysosomes. Over time, glycogen can accumulate inside cells and interfere with their usual structure and function. Muscle cells are particularly affected, which helps explain why muscle weakness is an important feature of Pompe disease.
The condition can affect skeletal muscles used for movement as well as muscles involved in breathing. In infantile-onset forms, the heart may also be significantly affected. Later-onset Pompe disease may develop at different ages and often involves gradually progressing muscle weakness and respiratory difficulties.
Understanding GAA gene changes provides important information about the biological processes involved in Pompe disease development. Genetic and enzyme testing may be used alongside clinical evaluation to better understand the condition and distinguish it from other disorders with similar symptoms. Continued research into genetic variations and cellular processes is also helping expand scientific understanding of how Pompe disease can differ between individuals.